Branford, CT, United States of America

Michael Jeffers

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 2003-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can gather, analyze, and present information about inventor Michael Jeffers. Here is the structured article based on the data provided:

Title: Unveiling the Innovations of Michael Jeffers: Pioneering Monoclonal Antibodies

Introduction:

In the realm of biomedical advancements, innovator Michael Jeffers has made significant contributions through his groundbreaking inventions. Hailing from Branford, CT (US), Jeffers is a prolific inventor with 8 patents to his name, revolutionizing the field with his cutting-edge research.

Latest Patents:

Jeffers' latest patents showcase his expertise in biopharmaceuticals, particularly in the development of monoclonal antibodies targeting essential antigens. The invention of antibodies against the T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen highlights his pioneering work in this domain. Additionally, his creation of antibodies directed to GPNMB demonstrates his commitment to advancing immunotherapy.

Career Highlights:

Throughout his career, Michael Jeffers has played a pivotal role in companies such as Curagen Corporation and Celldex Therapeutics Limited. His tenure in these esteemed organizations has shaped the landscape of biotechnology, paving the way for novel therapeutic interventions and medical breakthroughs.

Collaborations:

Jeffers has collaborated with esteemed colleagues such as William LaRochelle and Henri Lichenstein, fostering a culture of innovation and excellence. Together, they have synergized their expertise to drive forward transformative research initiatives, leaving an indelible mark on the scientific community.

Conclusion:

Michael Jeffers stands as a beacon of innovation in the world of biopharmaceuticals, spearheading advancements that have the potential to revolutionize healthcare. His pioneering work in monoclonal antibodies underscores his dedication to pushing the boundaries of scientific discovery, offering hope for a future where precision medicine reigns supreme.

If you need further information or have any specific requests, feel free to ask!

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…